Polaris Group (TPE:6550) Short Interest


TPE:6550 Polaris Group TPE:6550
59 GF Score
Price NT$13.05
GF Value NT$55.10
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Polaris Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:6550 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Polaris Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polaris Group Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Polaris Group's Short Interest falls into.


TPE:6550
59GF Score
Polaris Group TPE:6550
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Polaris Group (TPE:6550) Overvalued in 2026?

Based on GuruFocus' analysis, Polaris Group stock appears to be undervalued. The current stock price of NT$13.05 is trading 76.3% below its estimated GF Value™ of NT$55.10. GuruFocus considers Polaris Group to be Possible Value Trap.

Key valuation signals for TPE:6550:

  • Short Interest:
  • GF Value™: NT$55.10 vs. price of NT$13.05 (76.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the TPE:6550 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Polaris Group Business Description

Address Ugland House, PO Box 309, Grand Cayman, CYM, KY1-1104
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.
59GF Score

Get the complete analysis for TPE:6550

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.05
Price
NT$55.10
GF Value